Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | MME | P08473 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | PPM1B | O75688 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16202455 | 0.81 | CYP1A2 (0.43) | CYP1A2MMECYP2C19PPM1BKDM4E | |
| SCHEMBL8818955 | 0.80 | MME (0.42) | CYP1A2MMECYP2C19PPM1BKDM4E | |
| SCHEMBL8818604 | 0.79 | CYP2C19 (0.44) | CYP1A2MMECYP2C19PPM1BKDM4E | |
| SCHEMBL16202433 | 0.78 | MME (0.48) | CYP1A2MMECYP2C19PPM1BALDH1A1 | |
| SCHEMBL14674752 | 0.77 | ALDH1A1 (0.50) | CYP1A2CYP2C19PPM1BKDM4EALDH1A1 | |
| SCHEMBL3622599 | 0.75 | MME (0.40) | CYP1A2MMECYP2C19PPM1BKDM4E | |
| SCHEMBL5142303 | 0.75 | MME (0.40) | CYP1A2MMECYP2C19PPM1BKDM4E | |
| SCHEMBL2325576 | 0.75 | MME (0.40) | CYP1A2MMECYP2C19PPM1BKDM4E | |
| SCHEMBL16202440 | 0.75 | MME (0.41) | CYP1A2MMECYP2C19 | |
| SCHEMBL14357696 | 0.74 | MME (0.45) | CYP1A2MMECYP2C19PPM1BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3171171-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES (US) | 2018-07-18 | — | — | EP | claimed |
| EP-2788760-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES INC (US) | 2017-02-15 | — | — | EP | claimed |
| EP-2478049-B1 | A POLYMER SUPPORT | UNIV CAPE TOWN (ZA) | 2015-02-25 | — | — | EP | claimed |
| EP-2659901-B1 | Recombinant deamidated gliadin antigen | BIO RAD LABORATORIES (US) | 2015-01-21 | — | — | EP | claimed |
| EP-2276499-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES (US) | 2013-06-12 | — | — | EP | claimed |
| US-7538092-B2 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2009-05-26 | — | — | US | claimed |
| EP-1549350-B1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DE GMBH (DE) | 2008-09-24 | — | — | EP | claimed |
| US-20060100163-A1 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2006-05-11 | — | — | US | claimed |
| EP-1549350-A1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | Fresenius Kabi Deutschland GmbH (DE) | 2005-07-06 | — | — | EP | claimed |
| WO-2004032971-A1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2004-04-22 | — | — | WO | claimed |
| EP-1480681-B1 | COUPLING LOW-MOLECULAR SUBSTANCES TO A MODIFIED POLYSACCHARIDE | FRESENIUS KABI DE GMBH (DE) | 2011-04-20 | — | — | EP | disclosed |
| EP-2269655-A2 | Coupling of low molecular weight substances to hydroxyalkyl starch | Fresenius Kabi Deutschland GmbH (DE) | 2011-01-05 | — | — | EP | disclosed |
| US-7538092-B2 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2009-05-26 | — | — | US | disclosed |
| EP-1549350-B1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DE GMBH (DE) | 2008-09-24 | — | — | EP | disclosed |
| US-20060100163-A1 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2006-05-11 | — | — | US | disclosed |
| EP-1480682-A1 | COUPLING PROTEINS TO A MODIFIED POLYSACCHARIDE | Biotechnologie Gesellschaft Mittelhessen MBH (DE) | 2004-12-01 | — | — | EP | disclosed |
| EP-1480681-A2 | COUPLING LOW-MOLECULAR SUBSTANCES TO A MODIFIED POLYSACCHARIDE | Biotechnologie Gesellschaft Mittelhessen MBH (DE) | 2004-12-01 | — | — | EP | disclosed |
| WO-2004032971-A1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2004-04-22 | — | — | WO | disclosed |
| WO-2003074088-A2 | COUPLING LOW-MOLECULAR SUBSTANCES TO HYDROXYALKYL STARCH | BIOTECHNOLOGIE - GESELLSCHAFT MITTELHESSEN MBH (DE) | 2003-09-12 | — | — | WO | disclosed |
| WO-2003074087-A1 | COUPLING PROTEINS TO A MODIFIED POLYSACCHARIDE | BIOTECHNOLOGIE - GESELLSCHAFT MITTELHESSEN MBH (DE) | 2003-09-12 | — | — | WO | disclosed |